Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Current Assets (2020 - 2026)

Rani Therapeutics Holdings' Current Assets history spans 7 years, with the latest figure at $47.1 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 164.81% to $47.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $47.1 million, a 164.81% increase, with the full-year FY2025 number at $53.3 million, up 79.27% from a year prior.
  • Current Assets came in at $47.1 million for Q1 2026, down from $53.3 million in the prior quarter.
  • The five-year high for Current Assets was $109.3 million in Q1 2022, with the low at $5.0 million in Q3 2025.
  • Historically, Current Assets has averaged $56.4 million across 5 years, with a median of $50.8 million in 2023.
  • Biggest five-year swings in Current Assets: tumbled 84.69% in 2025 and later soared 164.81% in 2026.
  • Year by year, Current Assets stood at $100.9 million in 2022, then plummeted by 49.62% to $50.8 million in 2023, then plummeted by 41.5% to $29.7 million in 2024, then surged by 79.27% to $53.3 million in 2025, then dropped by 11.68% to $47.1 million in 2026.
  • Business Quant data shows Current Assets for RANI at $47.1 million in Q1 2026, $53.3 million in Q4 2025, and $5.0 million in Q3 2025.